April 6, 2026 · Form 4 insider transaction
Raday Gilead bought 30,780,000 shares of RedHill Biopharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 16 days after the transaction.
Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date.